Fractyl Health Statistics
Total Valuation
Fractyl Health has a market cap or net worth of $72.33 million. The enterprise value is $52.43 million.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Fractyl Health has 158.65 million shares outstanding. The number of shares has increased by 74.13% in one year.
| Current Share Class | 158.65M |
| Shares Outstanding | 158.65M |
| Shares Change (YoY) | +74.13% |
| Shares Change (QoQ) | +117.39% |
| Owned by Insiders (%) | 1.16% |
| Owned by Institutions (%) | 64.58% |
| Float | 136.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 7.39 |
| P/TBV Ratio | 7.65 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.78, with a Debt / Equity ratio of 6.52.
| Current Ratio | 4.78 |
| Quick Ratio | 4.45 |
| Debt / Equity | 6.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -744.17% and return on invested capital (ROIC) is -74.69%.
| Return on Equity (ROE) | -744.17% |
| Return on Assets (ROA) | -52.74% |
| Return on Invested Capital (ROIC) | -74.69% |
| Return on Capital Employed (ROCE) | -93.93% |
| Weighted Average Cost of Capital (WACC) | 5.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.40M |
| Employee Count | 101 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.93% in the last 52 weeks. The beta is 1.19, so Fractyl Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -58.93% |
| 50-Day Moving Average | 0.62 |
| 200-Day Moving Average | 1.30 |
| Relative Strength Index (RSI) | 39.80 |
| Average Volume (20 Days) | 2,108,574 |
Short Selling Information
The latest short interest is 5.83 million, so 3.68% of the outstanding shares have been sold short.
| Short Interest | 5.83M |
| Short Previous Month | 13.16M |
| Short % of Shares Out | 3.68% |
| Short % of Float | 4.28% |
| Short Ratio (days to cover) | 2.23 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -96.82M |
| Pretax Income | -140.95M |
| Net Income | -140.95M |
| EBITDA | -95.69M |
| EBIT | -96.82M |
| Earnings Per Share (EPS) | -$1.86 |
Full Income StatementBalance Sheet
The company has $81.54 million in cash and $61.65 million in debt, with a net cash position of $19.89 million or $0.13 per share.
| Cash & Cash Equivalents | 81.54M |
| Total Debt | 61.65M |
| Net Cash | 19.89M |
| Net Cash Per Share | $0.13 |
| Equity (Book Value) | 9.46M |
| Book Value Per Share | 0.06 |
| Working Capital | 69.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$90.33 million and capital expenditures -$557,000, giving a free cash flow of -$90.89 million.
| Operating Cash Flow | -90.33M |
| Capital Expenditures | -557,000 |
| Depreciation & Amortization | 1.13M |
| Net Borrowing | -457,000 |
| Free Cash Flow | -90.89M |
| FCF Per Share | -$0.57 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Fractyl Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -74.13% |
| Shareholder Yield | -74.13% |
| Earnings Yield | -194.88% |
| FCF Yield | -125.66% |
Analyst Forecast
The average price target for Fractyl Health is $5.40, which is 1,084.47% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.40 |
| Price Target Difference | 1,084.47% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
